Torys LLP acted as Canadian counsel to the underwriters. On November 5, 2021, Cardiol Therapeutics Inc. closed its previously announced public offering of 16,350,000 units at a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
